{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T03:11:09Z","timestamp":1787800269096,"version":"build-2784847793"},"reference-count":84,"publisher":"Oxford University Press (OUP)","issue":"2","license":[{"start":{"date-parts":[[2025,6,5]],"date-time":"2025-06-05T00:00:00Z","timestamp":1749081600000},"content-version":"vor","delay-in-days":155,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01AI153167"],"award-info":[{"award-number":["R01AI153167"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R21AI151654"],"award-info":[{"award-number":["R21AI151654"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,3,14]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Patients with systemic lupus erythematosus (SLE) have increased risk of developing atherosclerotic cardiovascular disease (ASCVD). This excessive risk starts to accumulate during the earliest stages of SLE. ASCVD in SLE is associated with an adverse outcome. SLE-enhanced atherogenesis is most likely the consequence of a complex interplay between traditional risk factors and chronic auto-immune inflammation. This underscores the importance of conscientious management of traditional risk factors as well as maintaining low SLE disease activity. Shared immune pathways in SLE and ASCVD can affect the vascular biology of the atherosclerotic process in patients with SLE. In this review, we will discuss how the ASCVD risk evolves during the SLE disease course, and we consider whether patients with SLE are prone to developing superficial erosion of atherosclerotic plaques. This is highly relevant as pilot studies in the general population suggest antithrombotic therapy without stenting could be the better therapeutic approach in patients with plaque erosion.<\/jats:p>","DOI":"10.1093\/rap\/rkaf048","type":"journal-article","created":{"date-parts":[[2025,6,5]],"date-time":"2025-06-05T05:39:47Z","timestamp":1749101987000},"source":"Crossref","is-referenced-by-count":7,"title":["Atherosclerotic cardiovascular disease in systemic lupus erythematosus: from preclinical lupus to atherosclerotic plaque erosion"],"prefix":"10.1093","volume":"9","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1432-069X","authenticated-orcid":false,"given":"Sander I","family":"van Leuven","sequence":"first","affiliation":[{"name":"Department of Rheumatology, Radboud University Medical Center , Nijmegen,","place":["The Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lenny","family":"van Bon","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, Radboud University Medical Center , Nijmegen,","place":["The Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robin","family":"Nijveldt","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Radboud University Medical Center , Nijmegen,","place":["The Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amy S","family":"Major","sequence":"additional","affiliation":[{"name":"Division of Rheumatology and Immunology, Department of Medicine, Vanderbilt University Medical Center , Nashville, TN,","place":["USA"]},{"name":"Vanderbilt Center for Immunobiology, Vanderbilt University Medical Center , Nashville, TN,","place":["USA"]},{"name":"Tennessee Valley Healthcare System, U.S. Department of Veterans Affairs , Nashville, TN,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2025,6,4]]},"reference":[{"key":"2025060501393975100_rkaf048-B1","doi-asserted-by":"crossref","first-page":"1826","DOI":"10.1136\/annrheumdis-2012-202398","article-title":"Cardiovascular comorbidities antedating the diagnosis of rheumatoid arthritis","volume":"72","author":"Kerola","year":"2013","journal-title":"Ann Rheum Dis"},{"key":"2025060501393975100_rkaf048-B2","doi-asserted-by":"crossref","first-page":"kead377","DOI":"10.1093\/rheumatology\/kead377","article-title":"Increased risk of cardiovascular disease preceding diagnosis of incident ANCA-associated vasculitis: a Danish nationwide study","volume":"63","author":"Nygaard","year":"2024","journal-title":"Rheumatology (Oxford)"},{"key":"2025060501393975100_rkaf048-B3","doi-asserted-by":"crossref","first-page":"680","DOI":"10.3899\/jrheum.130874","article-title":"Mortality and cardiovascular burden of systemic lupus erythematosus in a US population-based cohort","volume":"41","author":"Bartels","year":"2014","journal-title":"J Rheumatol"},{"key":"2025060501393975100_rkaf048-B4","doi-asserted-by":"crossref","first-page":"e000143","DOI":"10.1136\/lupus-2015-000143","article-title":"Cardiovascular events prior to or early after diagnosis of systemic lupus erythematosus in the systemic lupus international collaborating clinics cohort","volume":"3","author":"Urowitz","year":"2016","journal-title":"Lupus Sci Med"},{"key":"2025060501393975100_rkaf048-B5","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1093\/rheumatology\/key335","article-title":"Temporal relationships between systemic lupus erythematosus and comorbidities","volume":"58","author":"Kuo","year":"2019","journal-title":"Rheumatology (Oxford)"},{"key":"2025060501393975100_rkaf048-B6","doi-asserted-by":"crossref","first-page":"102692","DOI":"10.1016\/j.jaut.2021.102692","article-title":"Distinct patterns of comorbidity prior to diagnosis of incident systemic lupus erythematosus in the Danish population","volume":"123","author":"Hansen","year":"2021","journal-title":"J Autoimmun"},{"key":"2025060501393975100_rkaf048-B7","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1177\/0961203320983445","article-title":"Delayed diagnosis adversely affects outcome in systemic lupus erythematosus: cross sectional analysis of the LuLa cohort","volume":"30","author":"Kernder","year":"2021","journal-title":"Lupus"},{"key":"2025060501393975100_rkaf048-B8","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1056\/NEJMoa021933","article-title":"Development of autoantibodies before the clinical onset of systemic lupus erythematosus","volume":"349","author":"Arbuckle","year":"2003","journal-title":"N Engl J Med"},{"key":"2025060501393975100_rkaf048-B9","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1046\/j.1365-3083.2001.00959.x","article-title":"Development of anti-dsDNA autoantibodies prior to clinical diagnosis of systemic lupus erythematosus","volume":"54","author":"Arbuckle","year":"2001","journal-title":"Scand J Immunol"},{"key":"2025060501393975100_rkaf048-B10","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.jaut.2016.06.001","article-title":"Dysregulation of innate and adaptive serum mediators precedes systemic lupus erythematosus classification and improves prognostic accuracy of autoantibodies","volume":"74","author":"Lu","year":"2016","journal-title":"J Autoimmun"},{"key":"2025060501393975100_rkaf048-B11","doi-asserted-by":"crossref","first-page":"R30","DOI":"10.1186\/ar3258","article-title":"Autoantibodies predate the onset of systemic lupus erythematosus in northern Sweden","volume":"13","author":"Eriksson","year":"2011","journal-title":"Arthritis Res Ther"},{"key":"2025060501393975100_rkaf048-B12","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1177\/0961203314523869","article-title":"Cytokines in relation to autoantibodies before onset of symptoms for systemic lupus erythematosus","volume":"23","author":"Eriksson","year":"2014","journal-title":"Lupus"},{"key":"2025060501393975100_rkaf048-B13","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1136\/annrheumdis-2018-213386","article-title":"Prediction of autoimmune connective tissue disease in an at-risk cohort: prognostic value of a novel two-score system for interferon status","volume":"77","author":"Md Yusof","year":"2018","journal-title":"Ann Rheum Dis"},{"key":"2025060501393975100_rkaf048-B14","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/s13075-023-02997-w","article-title":"Interferon and interferon-induced cytokines as markers of impending clinical progression in ANA+ individuals without a systemic autoimmune rheumatic disease diagnosis","volume":"25","author":"Kim","year":"2023","journal-title":"Arthritis Res Ther"},{"key":"2025060501393975100_rkaf048-B15","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1136\/ard-2023-225349","article-title":"Blood RNA-sequencing across the continuum of ANA-positive autoimmunity reveals insights into initiating immunopathology","volume":"83","author":"Carter","year":"2024","journal-title":"Ann Rheum Dis"},{"key":"2025060501393975100_rkaf048-B16","doi-asserted-by":"crossref","first-page":"890522","DOI":"10.3389\/fimmu.2022.890522","article-title":"Understanding the concept of pre-clinical autoimmunity: prediction and prevention of systemic lupus erythematosus: identifying risk factors and developing strategies against disease development","volume":"13","author":"Choi","year":"2022","journal-title":"Front Immunol"},{"key":"2025060501393975100_rkaf048-B17","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1002\/acr.23495","article-title":"Endothelial dysfunction in early systemic lupus erythematosus patients and controls without previous cardiovascular events","volume":"70","author":"Taraborelli","year":"2018","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"2025060501393975100_rkaf048-B18","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1002\/acr.23018","article-title":"Risk of myocardial infarction and stroke in newly diagnosed systemic lupus erythematosus: a general population-based study","volume":"69","author":"Avi\u00f1a-Zubieta","year":"2017","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"2025060501393975100_rkaf048-B19","doi-asserted-by":"crossref","first-page":"84","DOI":"10.3899\/jrheum.220279","article-title":"Timing and predictors of incident cardiovascular disease in systemic lupus erythematosus: risk occurs early and highlights racial disparities","volume":"50","author":"Garg","year":"2023","journal-title":"J Rheumatol"},{"key":"2025060501393975100_rkaf048-B20","doi-asserted-by":"crossref","first-page":"1544","DOI":"10.1136\/annrheumdis-2016-210973","article-title":"Stroke in systemic lupus erythematosus: a Swedish population-based cohort study","volume":"76","author":"Arkema","year":"2017","journal-title":"Ann Rheum Dis"},{"key":"2025060501393975100_rkaf048-B21","doi-asserted-by":"crossref","first-page":"3170","DOI":"10.1002\/art.20556","article-title":"Outcomes of hospitalizations for myocardial infarctions and cerebrovascular accidents in patients with systemic lupus erythematosus","volume":"50","author":"Ward","year":"2004","journal-title":"Arthritis Rheum"},{"key":"2025060501393975100_rkaf048-B22","doi-asserted-by":"crossref","first-page":"570","DOI":"10.3899\/jrheum.080373","article-title":"Poor outcomes after acute myocardial infarction in systemic lupus erythematosus","volume":"36","author":"Shah","year":"2009","journal-title":"J Rheumatol"},{"key":"2025060501393975100_rkaf048-B23","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/j.mayocp.2020.04.044","article-title":"Acute myocardial infarction in autoimmune rheumatologic disease: a nationwide analysis of clinical outcomes and predictors of management strategy","volume":"96","author":"Mohamed","year":"2021","journal-title":"Mayo Clin Proc"},{"key":"2025060501393975100_rkaf048-B24","doi-asserted-by":"crossref","first-page":"101086","DOI":"10.1016\/j.cpcardiol.2021.101086","article-title":"Clinical outcomes of acute myocardial infarction hospitalizations with systemic lupus erythematosus: an analysis of nationwide readmissions database","volume":"47","author":"Sagheer","year":"2022","journal-title":"Curr Probl Cardiol"},{"key":"2025060501393975100_rkaf048-B25","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1186\/s13075-015-0552-2","article-title":"Increased 30-day and 1-year mortality rates and lower coronary revascularisation rates following acute myocardial infarction in patients with autoimmune rheumatic disease","volume":"17","author":"Van Doornum","year":"2015","journal-title":"Arthritis Res Ther"},{"key":"2025060501393975100_rkaf048-B26","doi-asserted-by":"crossref","first-page":"e026411","DOI":"10.1161\/JAHA.122.026411","article-title":"Outcomes following acute coronary syndrome in patients with and without rheumatic immune-mediated inflammatory diseases","volume":"11","author":"Wassif","year":"2022","journal-title":"J Am Heart Assoc"},{"key":"2025060501393975100_rkaf048-B27","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.amjcard.2018.09.043","article-title":"Acute myocardial infarction outcomes in systemic lupus erythematosus (from the nationwide inpatient sample)","volume":"123","author":"Ando","year":"2019","journal-title":"Am J Cardiol"},{"key":"2025060501393975100_rkaf048-B28","doi-asserted-by":"crossref","first-page":"1590","DOI":"10.3899\/jrheum.170241","article-title":"Mortality and functionality after stroke in patients with systemic lupus erythematosus","volume":"44","author":"Rossides","year":"2017","journal-title":"J Rheumatol"},{"key":"2025060501393975100_rkaf048-B29","first-page":"778","article-title":"Impact of systemic lupus erythematosus on in-hospital outcomes of peripheral artery disease-insight from the national inpatient sample database","volume":"35","author":"Shah","year":"2022","journal-title":"Proc (Bayl Univ Med Cent)"},{"key":"2025060501393975100_rkaf048-B30","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.1016\/j.numecd.2019.08.006","article-title":"Systemic lupus erythematosus is associated with poor outcome after acute myocardial infarction","volume":"29","author":"Ke","year":"2019","journal-title":"Nutr Metab Cardiovasc Dis"},{"key":"2025060501393975100_rkaf048-B31","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1093\/rheumatology\/kez456","article-title":"Outcomes of acute cardiovascular events in rheumatoid arthritis and systemic lupus erythematosus: a population-based study","volume":"59","author":"Lai","year":"2020","journal-title":"Rheumatology (Oxford)"},{"key":"2025060501393975100_rkaf048-B32","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1161\/CIRCINTERVENTIONS.108.788745","article-title":"Poor 1-year outcomes after percutaneous coronary interventions in systemic lupus erythematosus: report from the National Heart, Lung, and Blood Institute Dynamic Registry","volume":"1","author":"Maksimowicz-McKinnon","year":"2008","journal-title":"Circ Cardiovasc Interv"},{"key":"2025060501393975100_rkaf048-B33","doi-asserted-by":"crossref","first-page":"2512","DOI":"10.1093\/rheumatology\/kez639","article-title":"Percutaneous coronary intervention outcomes in patients with rheumatoid arthritis, systemic lupus erythematosus and systemic sclerosis","volume":"59","author":"Martinez","year":"2020","journal-title":"Rheumatology (Oxford)"},{"key":"2025060501393975100_rkaf048-B34","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1136\/annrheumdis-2015-207719","article-title":"Outcomes of percutaneous coronary intervention in patients with rheumatoid arthritis and systemic lupus erythematosus: an 11-year nationwide cohort study","volume":"75","author":"Lai","year":"2016","journal-title":"Ann Rheum Dis"},{"key":"2025060501393975100_rkaf048-B35","doi-asserted-by":"crossref","first-page":"1610","DOI":"10.1016\/j.athoracsur.2004.10.052","article-title":"Outcomes of coronary artery bypass grafting in patients with connective tissue diseases","volume":"79","author":"Birdas","year":"2005","journal-title":"Ann Thorac Surg"},{"key":"2025060501393975100_rkaf048-B36","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1016\/j.jtcvs.2014.11.038","article-title":"Outcomes of coronary artery bypass grafting in patients with inflammatory rheumatic diseases: an 11-year nationwide cohort study","volume":"149","author":"Lai","year":"2015","journal-title":"J Thorac Cardiovasc Surg"},{"key":"2025060501393975100_rkaf048-B37","doi-asserted-by":"crossref","first-page":"2017","DOI":"10.1136\/annrheumdis-2017-211608","article-title":"Long-term outcomes and secondary prevention after acute coronary events in patients with rheumatoid arthritis","volume":"76","author":"Mantel","year":"2017","journal-title":"Ann Rheum Dis"},{"key":"2025060501393975100_rkaf048-B38","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/0002-9343(76)90431-9","article-title":"The bimodal mortality pattern of systemic lupus erythematosus","volume":"60","author":"Urowitz","year":"1976","journal-title":"Am J Med"},{"key":"2025060501393975100_rkaf048-B39","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/0002-9343(87)90762-5","article-title":"Dyslipoproteinemia in systemic lupus erythematosus. Effect of corticosteroids","volume":"83","author":"Ettinger","year":"1987","journal-title":"Am J Med"},{"key":"2025060501393975100_rkaf048-B40","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/0002-9343(92)90578-Y","article-title":"Risk factors for coronary artery disease in patients with systemic lupus erythematosus","volume":"93","author":"Petri","year":"1992","journal-title":"Am J Med"},{"key":"2025060501393975100_rkaf048-B41","doi-asserted-by":"crossref","first-page":"2331","DOI":"10.1002\/1529-0131(200110)44:10<2331::AID-ART395>3.0.CO;2-I","article-title":"Traditional Framingham risk factors fail to fully account for accelerated atherosclerosis in systemic lupus erythematosus","volume":"44","author":"Esdaile","year":"2001","journal-title":"Arthritis Rheum"},{"key":"2025060501393975100_rkaf048-B42","doi-asserted-by":"crossref","first-page":"e000454","DOI":"10.1136\/lupus-2020-000454","article-title":"Patients with SLE have higher risk of cardiovascular events and mortality in comparison with controls with the same levels of traditional risk factors and intima-media measures, which is related to accumulated disease damage and antiphospholipid syndrome: a case-control study over 10 years","volume":"8","author":"Ajeganova","year":"2021","journal-title":"Lupus Sci Med"},{"key":"2025060501393975100_rkaf048-B43","doi-asserted-by":"crossref","first-page":"152468","DOI":"10.1016\/j.semarthrit.2024.152468","article-title":"Personalizing cardiovascular risk prediction for patients with systemic lupus erythematosus","volume":"67","author":"Choi","year":"2024","journal-title":"Semin Arthritis Rheum"},{"key":"2025060501393975100_rkaf048-B44","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1093\/rheumatology\/kead329","article-title":"Accelerated atherosclerosis in systemic lupus erythematosus: don't forget the devil we know!","volume":"63","author":"van Leuven","year":"2024","journal-title":"Rheumatology (Oxford)"},{"key":"2025060501393975100_rkaf048-B45","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1136\/annrheumdis-2021-221733","article-title":"EULAR recommendations for cardiovascular risk management in rheumatic and musculoskeletal diseases, including systemic lupus erythematosus and antiphospholipid syndrome","volume":"81","author":"Drosos","year":"2022","journal-title":"Ann Rheum Dis"},{"key":"2025060501393975100_rkaf048-B46","doi-asserted-by":"crossref","first-page":"3159","DOI":"10.1002\/art.11296","article-title":"Risk factors for coronary heart disease in women with systemic lupus erythematosus: the Toronto risk factor study","volume":"48","author":"Bruce","year":"2003","journal-title":"Arthritis Rheum"},{"key":"2025060501393975100_rkaf048-B47","doi-asserted-by":"crossref","first-page":"2399","DOI":"10.1056\/NEJMoa035471","article-title":"Prevalence and correlates of accelerated atherosclerosis in systemic lupus erythematosus","volume":"349","author":"Roman","year":"2003","journal-title":"N Engl J Med"},{"key":"2025060501393975100_rkaf048-B48","doi-asserted-by":"crossref","first-page":"2407","DOI":"10.1056\/NEJMoa035611","article-title":"Premature coronary-artery atherosclerosis in systemic lupus erythematosus","volume":"349","author":"Asanuma","year":"2003","journal-title":"N Engl J Med"},{"key":"2025060501393975100_rkaf048-B49","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1186\/s13075-014-0443-y","article-title":"Statin initiation and treatment non-adherence following a first acute myocardial infarction in patients with inflammatory rheumatic disease versus the general population","volume":"16","author":"Bohensky","year":"2014","journal-title":"Arthritis Res Ther"},{"key":"2025060501393975100_rkaf048-B50","doi-asserted-by":"crossref","first-page":"e447","DOI":"10.1016\/S2665-9913(24)00090-0","article-title":"Prevalence and target attainment of traditional cardiovascular risk factors in patients with systemic lupus erythematosus: a cross-sectional study including 3401 individuals from 24 countries","volume":"6","author":"Bolla","year":"2024","journal-title":"Lancet Rheumatol"},{"key":"2025060501393975100_rkaf048-B51","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/S0140-6736(04)16895-5","article-title":"Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS): multicentre randomised placebo-controlled trial","volume":"364","author":"Colhoun","year":"2004","journal-title":"Lancet"},{"key":"2025060501393975100_rkaf048-B52","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1136\/annrheumdis-2011-200071","article-title":"Mycophenolate mofetil but not atorvastatin attenuates atherosclerosis in lupus-prone LDLr(-\/-) mice","volume":"71","author":"van Leuven","year":"2012","journal-title":"Ann Rheum Dis"},{"key":"2025060501393975100_rkaf048-B53","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1002\/art.30645","article-title":"Use of atorvastatin in systemic lupus erythematosus in children and adolescents","volume":"64","author":"Schanberg","year":"2012","journal-title":"Arthritis Rheum"},{"key":"2025060501393975100_rkaf048-B54","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1136\/ard.2010.136762","article-title":"Lupus atherosclerosis prevention study (LAPS)","volume":"70","author":"Petri","year":"2011","journal-title":"Ann Rheum Dis"},{"key":"2025060501393975100_rkaf048-B55","doi-asserted-by":"crossref","first-page":"R117","DOI":"10.1186\/ar3402","article-title":"Influence of atorvastatin on coronary calcifications and myocardial perfusion defects in systemic lupus erythematosus patients: a prospective, randomized, double-masked, placebo-controlled study","volume":"13","author":"Plazak","year":"2011","journal-title":"Arthritis Res Ther"},{"key":"2025060501393975100_rkaf048-B56","first-page":"526","article-title":"Appropriate cardiovascular disease risk assessment in systemic lupus erythematosus may be lacking in rheumatology practice","volume":"36","author":"Esmaeilbeigi","year":"2018","journal-title":"Clin Exp Rheumatol"},{"key":"2025060501393975100_rkaf048-B57","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/s41927-020-0112-5","article-title":"Views of primary care physicians and rheumatologists regarding screening and treatment of hyperlipidemia among patients with rheumatoid arthritis","volume":"4","author":"Navarro-Mill\u00e1n","year":"2020","journal-title":"BMC Rheumatol"},{"key":"2025060501393975100_rkaf048-B58","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1093\/oxfordjournals.aje.a009122","article-title":"Age-specific incidence rates of myocardial infarction and angina in women with systemic lupus erythematosus: comparison with the Framingham study","volume":"145","author":"Manzi","year":"1997","journal-title":"Am J Epidemiol"},{"key":"2025060501393975100_rkaf048-B59","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1093\/rheumatology\/kem202","article-title":"Systemic inflammation as a risk factor for atherothrombosis","volume":"47","author":"van Leuven","year":"2008","journal-title":"Rheumatology (Oxford)"},{"key":"2025060501393975100_rkaf048-B60","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1038\/s41569-024-01045-7","article-title":"Autoimmune diseases and atherosclerotic cardiovascular disease","volume":"21","author":"Porsch","year":"2024","journal-title":"Nat Rev Cardiol"},{"key":"2025060501393975100_rkaf048-B61","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1038\/nri1882","article-title":"The immune response in atherosclerosis: a double-edged sword","volume":"6","author":"Hansson","year":"2006","journal-title":"Nat Rev Immunol"},{"key":"2025060501393975100_rkaf048-B62","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1038\/s41586-021-03392-8","article-title":"The changing landscape of atherosclerosis","volume":"592","author":"Libby","year":"2021","journal-title":"Nature"},{"key":"2025060501393975100_rkaf048-B63","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1038\/s41569-021-00542-3","article-title":"Plaque erosion and acute coronary syndromes: phenotype, molecular characteristics and future directions","volume":"18","author":"Fahed","year":"2021","journal-title":"Nat Rev Cardiol"},{"key":"2025060501393975100_rkaf048-B64","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1038\/s41569-022-00769-8","article-title":"Evolving concepts of the vulnerable atherosclerotic plaque and the vulnerable patient: implications for patient care and future research","volume":"20","author":"Gaba","year":"2023","journal-title":"Nat Rev Cardiol"},{"key":"2025060501393975100_rkaf048-B65","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.atherosclerosis.2020.10.016","article-title":"New prediction tools and treatment for ACS patients with plaque erosion","volume":"318","author":"Vergallo","year":"2021","journal-title":"Atherosclerosis"},{"key":"2025060501393975100_rkaf048-B66","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1038\/s41581-023-00797-8","article-title":"Vascular damage in systemic lupus erythematosus","volume":"20","author":"Ambler","year":"2024","journal-title":"Nat Rev Nephrol"},{"key":"2025060501393975100_rkaf048-B67","doi-asserted-by":"crossref","first-page":"538","DOI":"10.4049\/jimmunol.1100450","article-title":"Netting neutrophils induce endothelial damage, infiltrate tissues, and expose immunostimulatory molecules in systemic lupus erythematosus","volume":"187","author":"Villanueva","year":"2011","journal-title":"J Immunol"},{"key":"2025060501393975100_rkaf048-B68","doi-asserted-by":"crossref","first-page":"2199","DOI":"10.1136\/annrheumdis-2014-205365","article-title":"Peptidylarginine deiminase inhibition disrupts NET formation and protects against kidney, skin and vascular disease in lupus-prone MRL\/lpr mice","volume":"74","author":"Knight","year":"2015","journal-title":"Ann Rheum Dis"},{"key":"2025060501393975100_rkaf048-B69","doi-asserted-by":"crossref","first-page":"e99276","DOI":"10.1172\/jci.insight.99276","article-title":"Neutrophil subsets and their gene signature associate with vascular inflammation and coronary atherosclerosis in lupus","volume":"3","author":"Carlucci","year":"2018","journal-title":"JCI Insight"},{"key":"2025060501393975100_rkaf048-B70","doi-asserted-by":"crossref","first-page":"e144918","DOI":"10.1172\/JCI144918","article-title":"Bite of the wolf: innate immune responses propagate autoimmunity in lupus","volume":"131","author":"Gupta","year":"2021","journal-title":"J Clin Invest"},{"key":"2025060501393975100_rkaf048-B71","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1093\/eurheartj\/ehad720","article-title":"Platelet biology and function: plaque erosion vs. rupture","volume":"45","author":"Baaten","year":"2024","journal-title":"Eur Heart J"},{"key":"2025060501393975100_rkaf048-B72","first-page":"269","article-title":"Heart. Plaque erosion is a major substrate for coronary thrombosis in acute myocardial infarction","author":"Arbustini","year":"1999"},{"key":"2025060501393975100_rkaf048-B73","doi-asserted-by":"crossref","first-page":"1354","DOI":"10.1161\/01.CIR.93.7.1354","article-title":"Coronary plaque erosion without rupture into a lipid core. A frequent cause of coronary thrombosis in sudden coronary death","volume":"93","author":"Farb","year":"1996","journal-title":"Circulation"},{"key":"2025060501393975100_rkaf048-B74","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1007\/s11883-022-00980-5","article-title":"Sex differences in coronary atherosclerosis","volume":"24","author":"Sato","year":"2022","journal-title":"Curr Atheroscler Rep"},{"key":"2025060501393975100_rkaf048-B75","doi-asserted-by":"crossref","first-page":"e004506","DOI":"10.1161\/CIRCIMAGING.116.004506","article-title":"Sex differences in nonculprit coronary plaque microstructures on frequency-domain optical coherence tomography in acute coronary syndromes and stable coronary artery disease","volume":"9","author":"Kataoka","year":"2016","journal-title":"Circ Cardiovasc Imaging"},{"key":"2025060501393975100_rkaf048-B76","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1007\/s11239-019-01969-9","article-title":"Relative risk of plaque erosion among different age and sex groups in patients with acute coronary syndrome","volume":"49","author":"Kim","year":"2020","journal-title":"J Thromb Thrombolysis"},{"key":"2025060501393975100_rkaf048-B77","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1038\/ni0901-777","article-title":"Sex differences in autoimmune disease","volume":"2","author":"Whitacre","year":"2001","journal-title":"Nat Immunol"},{"key":"2025060501393975100_rkaf048-B78","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1177\/0961203310381512","article-title":"Relationship between cardiac symptoms, myocardial perfusion defects and coronary angiography findings in systemic lupus erythematosus","volume":"20","author":"Nikpour","year":"2011","journal-title":"Lupus"},{"key":"2025060501393975100_rkaf048-B79","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.jcmg.2010.09.019","article-title":"Myocardial ischemia in the absence of obstructive coronary artery disease in systemic lupus erythematosus","volume":"4","author":"Ishimori","year":"2011","journal-title":"JACC Cardiovasc Imaging"},{"key":"2025060501393975100_rkaf048-B80","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1038\/s41569-022-00687-9","article-title":"Optical coherence tomography in coronary atherosclerosis assessment and intervention","volume":"19","author":"Araki","year":"2022","journal-title":"Nat Rev Cardiol"},{"key":"2025060501393975100_rkaf048-B81","doi-asserted-by":"crossref","first-page":"2505","DOI":"10.1161\/CIRCULATIONAHA.110.955302","article-title":"High levels of systemic myeloperoxidase are associated with coronary plaque erosion in patients with acute coronary syndromes: a clinicopathological study","volume":"122","author":"Ferrante","year":"2010","journal-title":"Circulation"},{"key":"2025060501393975100_rkaf048-B82","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1016\/j.jacc.2018.06.072","article-title":"Alterations of hyaluronan metabolism in acute coronary syndrome: implications for plaque erosion","volume":"72","author":"Pedicino","year":"2018","journal-title":"J Am Coll Cardiol"},{"key":"2025060501393975100_rkaf048-B83","doi-asserted-by":"crossref","first-page":"2997","DOI":"10.1093\/eurheartj\/ehaa227","article-title":"Vulnerable plaques and patients: state-of-the-art","volume":"41","author":"Tomaniak","year":"2020","journal-title":"Eur Heart J"},{"key":"2025060501393975100_rkaf048-B84","doi-asserted-by":"crossref","first-page":"1638\u201339","DOI":"10.3899\/jrheum.2023-0552","article-title":"Are patients with systemic sclerosis subject to an increased risk of developing superficial erosion of atherosclerotic plaques?","volume":"50","author":"van Leuven","year":"2023","journal-title":"J Rheumatol"}],"container-title":["Rheumatology Advances in Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/rheumap\/article-pdf\/9\/2\/rkaf048\/63437740\/rkaf048.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/rheumap\/article-pdf\/9\/2\/rkaf048\/63437740\/rkaf048.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,5]],"date-time":"2025-06-05T05:40:00Z","timestamp":1749102000000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/rheumap\/article\/doi\/10.1093\/rap\/rkaf048\/8156940"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025]]},"references-count":84,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,3,14]]}},"URL":"https:\/\/doi.org\/10.1093\/rap\/rkaf048","relation":{},"ISSN":["2514-1775"],"issn-type":[{"value":"2514-1775","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025]]},"published":{"date-parts":[[2025]]},"article-number":"rkaf048"}}